Melissa Kerr

973 total citations
24 papers, 488 citations indexed

About

Melissa Kerr is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Melissa Kerr has authored 24 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in Melissa Kerr's work include Schizophrenia research and treatment (16 papers), Obsessive-Compulsive Spectrum Disorders (5 papers) and Bipolar Disorder and Treatment (4 papers). Melissa Kerr is often cited by papers focused on Schizophrenia research and treatment (16 papers), Obsessive-Compulsive Spectrum Disorders (5 papers) and Bipolar Disorder and Treatment (4 papers). Melissa Kerr collaborates with scholars based in Australia, United Kingdom and United States. Melissa Kerr's co-authors include Patrick D. McGorry, Stephen J. Wood, Gregor Berger, Connie Markulev, Barnaby Nelson, Michael Berk, Hok Pan Yuen, G. Paul Amminger, Alexandra Parker and Susy Harrigan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Research and The Journal of Clinical Psychiatry.

In The Last Decade

Melissa Kerr

21 papers receiving 476 citations

Peers

Melissa Kerr
Elena Huerta‐Ramos Spain
Amy Gillespie United Kingdom
Connie Markulev Australia
T. Rolfe Australia
Ángel Cabezas Spain
Carrie W. Holtzman United States
Michela Sala Italy
Raphaël Gourévitch France
Itxaso González–Ortega Spain
Avraham Reichenberg United States
Elena Huerta‐Ramos Spain
Melissa Kerr
Citations per year, relative to Melissa Kerr Melissa Kerr (= 1×) peers Elena Huerta‐Ramos

Countries citing papers authored by Melissa Kerr

Since Specialization
Citations

This map shows the geographic impact of Melissa Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Kerr more than expected).

Fields of papers citing papers by Melissa Kerr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Kerr. The network helps show where Melissa Kerr may publish in the future.

Co-authorship network of co-authors of Melissa Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Kerr. A scholar is included among the top collaborators of Melissa Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Kerr. Melissa Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, Daniel I., Rebecca E. Grattan, Tyler A. Lesh, et al.. (2026). Feasibility of a Stepped‐Care Intervention for Those at Clinical High Risk for Psychosis in the United States. Early Intervention in Psychiatry. 20(1). e70120–e70120.
2.
McRae, Allan F., Hok Pan Yuen, Anjali K. Henders, et al.. (2025). White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for Psychosis. Biological Psychiatry Global Open Science. 5(5). 100546–100546.
3.
4.
Horsham, Caitlin, Monika Janda, Melissa Kerr, H. Peter Soyer, & Liam J Caffery. (2022). Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging. Australasian Journal of Dermatology. 64(1). 118–121. 7 indexed citations
5.
Hartmann, Jessica, Barnaby Nelson, G. Paul Amminger, et al.. (2022). Baseline data of a sequential multiple assignment randomized trial (STEP study). Early Intervention in Psychiatry. 16(10). 1130–1142. 2 indexed citations
6.
O’Donoghue, Brian, Robert Hester, Susy Harrigan, et al.. (2021). Cognitive ability and metabolic physical health in first-episode psychosis. Schizophrenia Research Cognition. 24. 100194–100194. 8 indexed citations
7.
Filia, Kate, et al.. (2021). Understanding the Barriers and Facilitators to Employment for People with Bipolar Disorder. Psychiatric Quarterly. 92(4). 1565–1579. 8 indexed citations
8.
Francey, Shona M., Brian O’Donoghue, Barnaby Nelson, et al.. (2020). Psychosocial Intervention With or Without Antipsychotic Medication for First-Episode Psychosis: A Randomized Noninferiority Clinical Trial. Schizophrenia Bulletin Open. 1(1). 32 indexed citations
9.
Davey, Christopher G., Andrew M. Chanen, Sarah Hetrick, et al.. (2019). The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. The Lancet Psychiatry. 6(9). 735–744. 70 indexed citations
10.
Nelson, Barnaby, G. Paul Amminger, Hok Pan Yuen, et al.. (2017). Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients. Early Intervention in Psychiatry. 12(3). 292–306. 48 indexed citations
11.
Davey, Christopher G., Andrew M. Chanen, Sue Cotton, et al.. (2014). The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial. Trials. 15(1). 425–425. 11 indexed citations
12.
Francey, Shona M., Barnaby Nelson, Susy Harrigan, et al.. (2012). Should antipsychotic medication always be given for first-episode psychosis?. Own your potential (DEAKIN). 2 indexed citations
13.
Bartholomeusz, Cali F., Tina Proffitt, Greg Savage, et al.. (2011). Relational Memory in First Episode Psychosis: Implications for Progressive Hippocampal Dysfunction After Illness Onset. Australian & New Zealand Journal of Psychiatry. 45(3). 206–213. 17 indexed citations
14.
Court, Andrew, Melissa Kerr, Hok Pan Yuen, et al.. (2010). Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: A pilot study. Journal of Psychiatric Research. 44(15). 1027–1034. 37 indexed citations
15.
Smesny, Stefan, Ingo Willhardt, J. Lasch, et al.. (2010). Phospholipase A2activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12. The World Journal of Biological Psychiatry. 12(8). 598–607. 22 indexed citations
16.
Francey, Shona M., Barnaby Nelson, Andrew Thompson, et al.. (2010). Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophrenia Research. 119(1-3). 1–10. 74 indexed citations
17.
Garner, Belinda, Gregor Berger, Andrew Mackinnon, et al.. (2009). Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients. Schizophrenia Research. 113(1). 65–71. 30 indexed citations
18.
Berger, Gregor, Belinda Garner, Dennis Velakoulis, et al.. (2009). The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study. Schizophrenia Research. 116(1). 49–54. 26 indexed citations
19.
Kerr, Melissa, Sue Cotton, Tina Proffitt, et al.. (2008). The topical niacin sensitivity test: An inter- and intra-rater reliability study in healthy controls. Prostaglandins Leukotrienes and Essential Fatty Acids. 79(1-2). 15–19. 5 indexed citations
20.
Berger, Gregor, Tina‐Marie Proffitt, Melissa Kerr, et al.. (2008). Dosing Quetiapine in Drug-Naive First-Episode Psychosis. The Journal of Clinical Psychiatry. 69(11). 1702–1714. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Huerta‐Ramos Breakdown of academic impact, for papers by Amy Gillespie Breakdown of academic impact, for papers by Connie Markulev Breakdown of academic impact, for papers by T. Rolfe Breakdown of academic impact, for papers by Ángel Cabezas Breakdown of academic impact, for papers by Carrie W. Holtzman Breakdown of academic impact, for papers by Michela Sala Breakdown of academic impact, for papers by Raphaël Gourévitch Breakdown of academic impact, for papers by Itxaso González–Ortega Breakdown of academic impact, for papers by Avraham Reichenberg
Rankless by CCL
2026